Verseon's drug discovery platform is applicable to any clinical target with a known protein structure and, as such, provides the company with great program flexibility.
Verseon has used its drug discovery platform to build its drug portfolio comprising three different therapeutic areas.
Verseon is actively evaluating targets for future development. Selection is based on careful planning and involves several criteria including:
- Unmet market need
- Available target structure
- Favorable preclinical and clinical endpoints